Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply
- PMID: 35092057
- DOI: 10.1111/apt.16765
Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply
Comment on
-
Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver.Aliment Pharmacol Ther. 2022 Jan;55(1):97-107. doi: 10.1111/apt.16706. Epub 2021 Nov 24. Aliment Pharmacol Ther. 2022. PMID: 34820871
-
Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma?Aliment Pharmacol Ther. 2022 Feb;55(4):479-480. doi: 10.1111/apt.16732. Aliment Pharmacol Ther. 2022. PMID: 35092049 No abstract available.
References
REFERENCES
-
- Wang J, Pillai A. Editorial: concurrent fatty liver and chronic viral hepatitis-a dual calamity leading to increased risk of hepatocellular carcinoma? Aliment Pharmacol Ther. 2022;55:479-480.
-
- Kim MN, Han K, Yoo J, Hwang SG, Ahn SH. Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver. Aliment Pharmacol Ther. 2022;55:97-107.
-
- Lee Y-H, Bang H, Park YM, et al. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS One. 2014;9:e107584.
-
- Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
-
- Wong V-S, Chan SL, Mo F, et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol. 2010;28:1660-1665.
Publication types
MeSH terms
LinkOut - more resources
Medical